Skip to main content

Experiences with Administration of Marihuana to Glaucoma Patients

  • Chapter
The Therapeutic Potential Of Marihuana

Abstract

In 1971 Hepler and Frank reported reduction in intraocular pressure occurring after healthy young adults smoked marihuana. These initial observations led to additional studies designed to compare the pressure-reducing effects of placebo, smoked marihuana, and injected THC. Consistent, statistically-significant pressure reduction was observed in double-blind studies. Drop in intraocular pressure (IOP) was also observed in hospitalized subjects observed repeatedly for 12-hour periods. Additional hospitalized subjects were permitted to smoke marihuana ad libitum during a 5 1/2-hour period and comparisons were made between the pressure-reducing effects of smoking varying numbers of marihuana cigarettes. It was observed, for instance, that a subject smoking 22 cigarettes had only a slight further decrease in IOP as compared with a subject who smoked only 2 cigarettes. Hospitalized subjects observed for a total of 35 days, and other subjects observed for a total of 94 days, continued during these periods of prolonged chronic use of marihuana to show decrease in IOP with each period of intoxication. The results of these various investigations were reported at the International Conference on the Pharmacology of Cannabis, Savannah, Georgia, on December 4, 1974 (Hepler, Frank and Petrus, 1974). Graphical representation of the data is given in Figures 1–4. Publications by Shapiro (1974), Green and Podos (1974),and Purnell and Gregg (1975), among others, have confirmed the apparent IOP-reducing effect of marihuana and cannabinoids.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Green, K., & Podos, S. M. Antagonism of arachidonic acid-induced ocular effects by delta-tetrahydrocannabinol. Investigative Ophthalmology, June 1974.

    Google Scholar 

  • Hepler, R. S., & Frank, I. R. Marijuana smoking and intraocular pressure. JAMA, 1971, 217, 1392.

    Article  PubMed  CAS  Google Scholar 

  • Hepler, R. S., Frank, I. R., & Petrus, R. J. Ocular effects of marijuana smoking. International Conference on the Pharmacology of Cannabis, Savannah, Georgia, December 4, 1974, in press.

    Google Scholar 

  • Purnell, W. D., & Gregg, J. M. Delta-9-Tetrahydrocannabinol, euphoria and intraocular pressure in man. Annals of Ophthalmology, July 1975.

    Google Scholar 

  • Shapiro, D. The ocular manifestations of the cannabinols. Ophthalmologica, 1974, 168, 366–369.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Plenum Publishing Corporation

About this chapter

Cite this chapter

Hepler, R.S., Petrus, R.J. (1976). Experiences with Administration of Marihuana to Glaucoma Patients. In: Cohen, S., Stillman, R.C. (eds) The Therapeutic Potential Of Marihuana. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4286-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-4286-1_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4288-5

  • Online ISBN: 978-1-4613-4286-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics